Welcome to Shaping Tomorrow

Global Scans · Diabetes · Weekly Summary


  • [New] Ozempic, which is approved to treat diabetes, and Novo Nordisk's Wegovy, approved to treat overweight and obesity, are both approved to lower the risk of heart disease risk by 20%. Time
  • A simple home blood test could make it easier and quicker to study new treatments for type 1 diabetes that address its root cause. Diabetes UK
  • About 42% of adults are obese, with obesity strongly associated with metabolic disorders such as type 2 diabetes, hypertension, and dyslipidaemia conditions that collectively comprise metabolic syndrome and significantly increase cardiovascular risk. Persistence Market Research
  • While GLP-1 - analogous drugs have US Food and Drug Administration approval for type 2 diabetes and weight-loss treatment, they are not free of side effects or risks. New Atlas

Last updated: 13 September 2026



Please stand by...

The magic is happening, but it might take a couple of minutes.

Login